This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Small intestine
CD2_BENIGN_SMALL_INTESTINE_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Small intestine
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Small intestine
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1382 | 778 | 604 |
| Unadjusted period prevalence (%) | 0.27 | 0.27 | 0.27 |
| Median age at first event (years) | 63.28 | 61.65 | 65.38 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1258
- Matched controls
- 12581
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
17.4
323.0
1021
2498
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
+∞
323.0
765
*
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
+∞
323.0
480
*
UJF32
NOMESCO Finland
Coloscopy
4.8
134.9
608
2044
130
Kela drug reimbursment
Malignant tumour
+∞
118.6
112
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
41.2
113.7
143
39
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
17.6
113.3
183
120
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
161.2
86.2
90
6
JN4BD
NOMESCO Finland
Extensive body CT
8.0
81.3
196
282
C61
ICD-10 Finland
Malignant neoplasm of prostate
423.4
80.9
80
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
77.9
74
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.0
68.5
570
2723
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.9
67.0
245
594
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
94.0
64.6
71
8
A03FA01
ATC
metoclopramide; systemic, rectal
4.1
64.4
286
837
WX302
NOMESCO Finland
Thoracal epidural anesthesy
13.8
64.1
113
89
115
Kela drug reimbursment
Breast cancer
+∞
63.0
60
*
A04AA02
ATC
granisetron; systemic, transdermal
638.1
62.3
61
*
JDH05
NOMESCO Finland
Endoscopic polypectomy in duodenum
+∞
60.9
58
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
16.8
60.3
98
63
H02AB02
ATC
dexamethasone; systemic
18.4
59.9
94
55
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
59.8
57
*
A02BC02
ATC
pantoprazole; systemic
2.8
58.6
939
6438
UJF92
NOMESCO Finland
Capsular endoscopy
13.6
58.1
103
82
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
4.5
55.8
219
563
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
72.2
54.6
62
9
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
5.7
53.7
165
324
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.7
51.5
189
452
116
Kela drug reimbursment
Prostate cancer
+∞
50.3
48
*
UJF30
NOMESCO Finland
Ileoscopy through colon
4.0
49.2
216
613
ZX120
NOMESCO Finland
Intravenous
4.7
47.3
172
406
D64.9
ICD-10 Finland
Anaemia, unspecified
3.7
46.8
230
718
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
474.3
46.6
46
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
46.1
44
*
PJA12
NOMESCO Finland
Sentinel node biopsy
162.5
45.1
47
*
A02BC05
ATC
esomeprazole; systemic
2.4
44.9
628
3742
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
44.8
395
1842
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.5
44.0
233
769
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
72.6
43.3
49
7
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.7
42.3
348
1544
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.3
42.0
170
444
JLC30
NOMESCO Finland
Pancreatoduodenectomy
151.7
42.0
44
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
41.3
305
1264
UJF02
NOMESCO Finland
Peroral enteroscopy
38.6
41.2
52
14
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.4
40.6
221
741
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
5.0
40.6
137
297
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
39.8
38
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
39.6
361
1690
SPAT1236
SPAT
Informing family of child’s disability
7.8
39.2
93
127
Z51.88
ICD-10 Finland
Other specified medical care
10.1
38.9
79
83
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
38.7
37
*
JFB00
NOMESCO Finland
Partial resection of small intestine
14.8
38.5
65
46
A02BC01
ATC
omeprazole; systemic
2.3
37.9
452
2429
L02BG04
ATC
letrozole; oral
51.7
37.8
45
9
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
28.8
37.0
50
18
Z2221
NOMESCO Finland
Medical doctor
2.4
36.8
417
2178
Z71.9
ICD-10 Finland
Counselling, unspecified
4.3
36.3
144
367
L03AA13
ATC
pegfilgrastim; parenteral
367.1
36.1
36
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
35.6
214
768
WF002
NOMESCO Finland
Radical radiotherapy
44.4
35.2
43
10
JN4AD
NOMESCO Finland
Body CT examination
5.8
35.1
104
193
R4110
NOMESCO Finland
Physiotherapy
2.3
34.0
392
2050
Z26.9
ICD-10 Finland
Need for immunization against unspecified infectious disease
11.0
33.7
65
62
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
33.5
321
1525
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
6.7
33.4
88
140
A09AA02
ATC
multienzymes (lipase, protease etc.)
10.3
33.1
66
67
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
10.0
33.1
67
70
N02AA05
ATC
oxycodone; systemic
3.0
33.1
212
791
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
5.8
32.9
96
175
L03AA02
ATC
filgrastim; parenteral
174.4
32.9
34
*
L01BC06
ATC
capecitabine; oral
+∞
32.4
31
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.9
32.4
112
248
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
32.4
616
3997
WX002
NOMESCO Finland
Sedation and analgesia
2.4
31.7
334
1658
B01AB05
ATC
enoxaparin; parenteral
2.2
31.6
423
2358
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
5.0
31.4
105
224
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
31.4
30
*
WX402
NOMESCO Finland
General anaesthesia
2.9
31.4
218
857
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
30.9
219
870
L02BA01
ATC
tamoxifen; oral
87.3
30.9
34
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.6
30.7
269
1211
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
30.3
29
*
L02AE02
ATC
leuprorelin; implant, parenteral
25.5
30.2
42
17
JN3AD
NOMESCO Finland
Abdominal CT examination
3.7
30.0
139
406
A04AA01
ATC
ondansetron; systemic, rectal
7.4
30.0
73
104
UJD02
NOMESCO Finland
Gastroscopy
4.7
29.9
107
246
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
46.2
29.7
36
8
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
29.2
174
615
Z01.7
ICD-10 Finland
Laboratory examination
2.9
29.2
198
762
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.5
29.2
78
127
HAB40
NOMESCO Finland
Wedge excision of mammary gland
41.1
29.1
36
9
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
298.3
28.9
29
*
N02BE01
ATC
paracetamol; systemic, rectal
2.5
28.9
1103
9325
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.2
28.4
112
283
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
28.2
27
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
28.2
27
*
2115X
ICD-9 Finland
Benign neoplasm of other parts of digestive system, Liver and biliary passages[NEOPLASMA BENIGNUM ALIUD HEPATIS, VESIC FELLEAE ET]
+∞
28.2
27
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
27.7
150
495
Z3231
NOMESCO Finland
Registered nurse
2.1
27.6
391
2206
Z50.1
ICD-10 Finland
Other physical therapy
3.7
27.4
127
370
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
27.2
26
*
JAH00
NOMESCO Finland
Laparotomy
7.7
27.1
64
87
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
20.6
27.1
40
20
WW500
NOMESCO Finland
Blood transfusion
6.8
26.9
69
106
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
26.9
367
2034
Z51.5
ICD-10 Finland
Palliative care
6.9
26.8
68
103
JFA05
NOMESCO Finland
Endoscopic polypectomy in small intestine
98.8
26.7
29
*
Z3226
NOMESCO Finland
Physiotherapist
2.3
26.6
288
1433
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
26.1
25
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
26.1
25
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
11.8
26.0
48
42
N02AX02
ATC
tramadol; systemic, rectal
1.9
25.8
571
3813
ZX090
NOMESCO Finland
Other technic of radiotherapy
95.4
25.7
28
*
J01DB01
ATC
cefalexin; oral
2.1
24.6
1014
8395
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
4.6
24.6
88
202
UJK02
NOMESCO Finland
ERCP
6.5
24.5
65
105
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
5.7
24.3
71
130
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
6.0
24.3
68
118
JN4CD
NOMESCO Finland
Very extensive body CT
7.9
24.2
56
74
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
5.2
24.2
77
156
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
24.1
517
3386
A02BC03
ATC
lansoprazole; oral
1.9
23.5
435
2691
K92.1
ICD-10 Finland
Melaena
3.8
23.5
104
292
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
23.2
362
2096
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
23.0
22
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
23.0
22
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
23.0
22
*
Z13.5
ICD-10 Finland
Special screening examination for eye and ear disorders
8.0
22.9
52
67
L02BB03
ATC
bicalutamide; oral
233.9
22.7
23
*
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
7.1
22.7
56
82
K22.1
ICD-10 Finland
Ulcer of oesophagus
6.9
22.6
57
86
P01AB01
ATC
metronidazole; oral, rectal
1.8
22.3
503
3329
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.0
22.2
140
510
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
9.0
22.2
47
54
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
22.0
470
3045
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
223.5
21.7
22
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.0
21.5
89
235
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
21.4
441
2816
WZC30
SPAT
NA
5.4
21.4
65
125
A02BA02
ATC
ranitidine; systemic
2.0
21.1
302
1682
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
20.9
20
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
20.9
20
*
K29.4
ICD-10 Finland
Chronic atrophic gastritis
5.3
20.8
65
129
NK6AN
NOMESCO Finland
Total body bone isotope imaging
37.9
20.8
26
7
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
15.1
20.7
34
23
Z01.3
ICD-10 Finland
Examination of blood pressure
8.4
20.5
45
55
XW000
NOMESCO Finland
Bone marrow biopsy
5.4
20.2
61
117
J01MA12
ATC
levofloxacin; systemic
2.1
20.1
261
1390
R4190
NOMESCO Finland
Nutritional therapy
6.0
20.1
56
97
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
7.1
20.0
49
71
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
19.8
19
*
JDH52
NOMESCO Finland
Endoscopic mucosal or submucosal resection in duodenum
+∞
19.8
19
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
19.8
19
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
7.7
19.8
46
62
B03BA03
ATC
hydroxocobalamin; parenteral
3.2
19.7
111
374
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.8
19.2
84
233
ZXE00
NOMESCO Finland
One hour or less
1.8
19.2
494
3363
XX3DW
NOMESCO Finland
Time consuming IT work
3.7
19.2
86
244
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
19.2
260
1410
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
4.9
19.2
63
133
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
9.3
18.9
39
43
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
18.9
229
1182
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
18.9
396
2520
K29.3
ICD-10 Finland
Chronic superficial gastritis
4.1
18.8
75
192
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
18.8
18
*
JDH50
NOMESCO Finland
Local excision of lesion of duodenal bulb
+∞
18.8
18
*
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
28.3
18.8
25
9
Z12.3
ICD-10 Finland
Special screening examination for neoplasm of breast
9.1
18.7
39
44
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
19.0
18.7
28
15
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
21.2
18.6
27
13
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.7
18.6
84
240
WF049
NOMESCO Finland
Radiotherapy of metastasis
192.6
18.6
19
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.6
18.6
54
99
K30
ICD-10 Finland
Functional dyspepsia
2.4
18.5
169
761
HA1AA
NOMESCO Finland
X-ray mammography
4.7
18.5
63
138
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
6.5
18.5
48
76
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
12.1
18.3
33
28
K31.7
ICD-10 Finland
Polyp of stomach and duodenum
13.8
18.3
31
23
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
18.3
137
556
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.9
18.2
118
437
N03AX16
ATC
pregabalin; oral
1.9
18.2
319
1902
J01MA02
ATC
ciprofloxacin; systemic
1.7
18.2
498
3441
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
33.4
18.0
23
7
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
13.2
18.0
31
24
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.5
17.9
157
691
SPAT1285
SPAT
Provision of consultation response
3.1
17.8
103
355
L02BG06
ATC
exemestane; oral
+∞
17.7
17
*
A04AD12
ATC
aprepitant; systemic
+∞
17.7
17
*
JDA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in stomach or pylorus
37.2
17.6
22
6
Z25.1
ICD-10 Finland
Need for immunization against influenza
3.1
17.5
100
341
ZXA00
NOMESCO Finland
Right side
1.8
17.1
375
2406
H02AB06
ATC
prednisolone; systemic
1.7
17.1
601
4440
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
17.1
150
662
N05CF01
ATC
zopiclone; oral
1.7
17.1
432
2899
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
8.0
16.9
38
49
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
16.7
16
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
16.7
16
*
UKC02
NOMESCO Finland
Cystoscopy
2.1
16.5
207
1080
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
172.0
16.5
17
*
JAH01
NOMESCO Finland
Laparoscopy
4.1
16.5
65
165
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
10.9
16.5
31
29
K56.7
ICD-10 Finland
Ileus, unspecified
7.1
16.5
40
58
C03CA01
ATC
furosemide; systemic
1.7
16.3
419
2815
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.5
16.3
58
134
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
8.0
16.1
36
46
L02BG03
ATC
anastrozole; oral
48.1
16.0
19
*
R03AC02
ATC
salbutamol; inhalant
1.6
16.0
640
4864
R52.9
ICD-10 Finland
Pain, unspecified
2.5
16.0
127
532
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
15.9
142
630
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
15.9
223
1217
A06AD11
ATC
lactulose; oral
2.1
15.8
201
1053
XFE00
NOMESCO Finland
Epicardial ultrasonography
4.0
15.7
63
163
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
15.6
15
*
N06AB04
ATC
citalopram; systemic
1.9
15.6
281
1678
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
2.3
15.6
160
760
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
15.6
241
1363
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
86.1
15.6
17
*
A07AA02
ATC
nystatin; oral
2.8
15.6
103
387
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.6
15.5
45
83
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.7
15.5
44
79
B01AB10
ATC
tinzaparin; parenteral
3.2
15.4
84
278
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
8.8
15.2
32
37
D50.8
ICD-10 Finland
Other iron deficiency anaemias
6.5
15.1
39
62
3AC01
NOMESCO Finland
NA
8.4
14.8
32
39
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
25.3
14.7
20
8
B80
ICPC
Iron deficiency anaemia
5.1
14.7
46
93
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
14.6
14
*
8240/3-C17.9
ICD-O-3
Neuroendocrine tumor, NOS, of small intestine, NOS
+∞
14.6
14
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
14.6
14
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
14.6
14
*
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
14.4
14.6
24
17
Y77
ICPC
Malignant neoplasm prostate
151.6
14.5
15
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
151.6
14.5
15
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.5
14.5
114
475
WX892
NOMESCO Finland
Monitored bed care
2.5
14.5
117
495
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.0
14.4
46
95
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
14.4
263
1578
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
14.4
197
1063
ZXD05
NOMESCO Finland
Urgent procedure
1.7
14.3
370
2471
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.7
14.3
103
407
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
14.3
803
6580
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.1
14.3
79
265
K63.8
ICD-10 Finland
Other specified diseases of intestine
22.5
14.2
20
9
WZC30
NOMESCO Finland
Teaching
2.3
14.1
138
642
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
3.5
13.9
64
187
107
Kela drug reimbursment
Pernicious anaemia
4.8
13.9
46
99
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
30.4
13.9
18
6
K22.9
ICD-10 Finland
Disease of oesophagus, unspecified
17.8
13.8
21
12
H02AB07
ATC
prednisone; oral
2.0
13.8
202
1114
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.1
13.8
54
137
XF404
NOMESCO Finland
Ambulatory ECG
2.2
13.8
148
718
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
13.8
85
306
R06.0
ICD-10 Finland
Dyspnoea
1.7
13.7
335
2199
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
13.7
192
1045
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
13.6
13
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
13.6
13
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
13.6
13
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
13.6
13
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
13.6
13
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
13.6
13
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
13.6
13
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
13.5
234
1375
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.4
13.3
34
54
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.1
13.2
159
810
K83.1
ICD-10 Finland
Obstruction of bile duct
9.8
13.2
26
27
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
4.2
13.1
49
120
K29.7
ICD-10 Finland
Gastritis, unspecified
3.2
13.1
68
219
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
3.6
13.0
58
166
M04AA01
ATC
allopurinol; systemic
2.0
13.0
181
982
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
12.9
327
2161
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
13.1
12.9
22
17
A79
ICPC
Malignancy NOS
50.5
12.9
15
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
50.5
12.9
15
*
R50.9
ICD-10 Finland
Fever, unspecified
2.1
12.8
158
815
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.0
12.7
75
263
A03FA02
ATC
cisapride; oral, rectal
2.3
12.7
124
575
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
12.7
558
4253
JFA73
NOMESCO Finland
Excision of lesion of small intestine
70.5
12.6
14
*
K59.0
ICD-10 Finland
Constipation
2.7
12.6
86
331
OAB50
SPAT
NA
4.7
12.5
42
92
K29.8
ICD-10 Finland
Duodenitis
8.8
12.5
26
30
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
12.5
12
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
12.5
12
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
12.5
12
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
12.5
12
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
12.5
12
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
12.5
12
*
189
Kela drug reimbursment
Imatinib
+∞
12.5
12
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
12.5
12
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
12.5
12
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.3
12.4
120
557
R13
ICD-10 Finland
Dysphagia
2.6
12.3
94
384
WX110
NOMESCO Finland
Local anesthesy
1.5
12.2
761
6267
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.8
12.0
51
140
K83.0
ICD-10 Finland
Cholangitis
6.0
12.0
32
54
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.3
11.9
43
102
ZXA05
NOMESCO Finland
Left side
1.6
11.7
328
2221
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
30.3
11.6
15
5
H01CB02
ATC
octreotide; parenteral
65.5
11.6
13
*
G44.2
ICD-10 Finland
Tension-type headache
2.0
11.6
157
838
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
4.7
11.6
38
82
M79.6
ICD-10 Finland
Pain in limb
1.6
11.6
431
3135
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
9.3
11.5
23
25
L01XE01
ATC
[U] imatinib; oral
+∞
11.5
11
*
8240/3-C17.2
ICD-O-3
Neuroendocrine tumor, NOS, of ileum
+∞
11.5
11
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
11.5
11
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
11.5
11
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
11.5
11
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
11.5
11
*
JDA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in stomach or pylorus
+∞
11.5
11
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
11.5
11
*
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
+∞
11.5
11
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
11.5
11
*
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
11.5
11
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.0
11.5
66
228
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
13.7
11.5
19
14
R12
ICD-10 Finland
Heartburn
2.4
11.4
103
459
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
11.4
103
459
J01FA06
ATC
roxithromycin; oral
1.5
11.4
482
3610
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
121.0
11.4
12
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.0
11.4
66
229
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.0
11.4
66
229
Z71.8
ICD-10 Finland
Other specified counselling
1.7
11.4
263
1685
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
17.2
11.2
17
10
N06AX21
ATC
duloxetine; oral
2.1
11.2
130
655
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
25.2
11.1
15
6
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
11.1
136
698
UJH02
NOMESCO Finland
Anoscopy
2.9
11.1
65
228
C07AB07
ATC
bisoprolol; oral
1.5
11.0
629
5029
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
6.7
11.0
27
41
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
11.0
215
1308
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
14.0
11.0
18
13
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.2
11.0
41
101
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
43.7
10.9
13
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.4
10.9
91
390
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
4.9
10.7
34
71
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
10.7
128
650
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
10.6
64
229
WF004
NOMESCO Finland
Palliative radiotherapy
60.5
10.6
12
*
JDA42
NOMESCO Finland
Other endoscopic haemostatic procedure in stomach or pylorus
11.3
10.6
19
17
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
10.6
213
1308
A02BC04
ATC
rabeprazole; oral
2.1
10.5
121
605
R11
ICD-10 Finland
Nausea and vomiting
2.3
10.5
97
437
R60.0
ICD-10 Finland
Localized oedema
2.0
10.5
147
794
Z12.1
ICD-10 Finland
Special screening examination for neoplasm of intestinal tract
9.3
10.5
21
23
R51.80
ICD-10 Finland
Headache
1.9
10.5
162
909
K29.1
ICD-10 Finland
Other acute gastritis
5.3
10.5
31
60
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
10.5
183
1074
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.9
10.4
172
987
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
110.8
10.4
11
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
10.4
10
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
10.4
10
*
X76
ICPC
Malignant neoplasm breast female
+∞
10.4
10
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
10.4
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
10.4
10
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
10.4
10
*
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
+∞
10.4
10
*
JDH28
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in duodenum
+∞
10.4
10
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
10.4
10
*
21121
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Duodeni
+∞
10.4
10
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
10.4
10
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
10.4
148
808
R52.0
ICD-10 Finland
Acute pain
4.0
10.3
40
102
WF003
NOMESCO Finland
Adjuvant radiotherapy
32.8
10.3
13
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
10.3
290
1958
RD210
NOMESCO Finland
NA
4.9
10.2
32
66
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.7
10.2
68
258
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
10.2
278
1860
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.6
10.2
44
124
XKD00
NOMESCO Finland
Uroflowmetry
1.8
10.2
173
1003
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.0
10.1
134
710
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.8
10.0
63
231
Z98.8
ICD-10 Finland
Other specified postsurgical states
6.5
10.0
25
39
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
10.0
177
1040
UJG02
NOMESCO Finland
Proctoscopy
4.8
10.0
32
68
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
40.4
10.0
12
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.6
10.0
43
121
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.1
9.9
110
541
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
9.9
91
412
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
9.9
245
1594
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.2
9.9
36
87
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.1
9.9
54
182
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
6.3
9.9
25
40
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
9.8
95
438
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.3
9.8
87
386
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
9.6
9.8
19
20
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.9
9.7
39
103
S18
ICPC
Laceration/cut
1.5
9.7
485
3734
D75
ICPC
Malignant neoplasm colon/rectum
55.4
9.7
11
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
55.4
9.7
11
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.2
9.7
101
484
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
9.6
94
438
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
9.6
411
3057
C08CA01
ATC
amlodipine; oral
1.5
9.6
474
3636
A11CC03
ATC
alfacalcidol; systemic
3.6
9.5
41
116
TJX22
NOMESCO Finland
Excision of local lesion in gastrointestinal endoscopy
100.7
9.4
10
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
9.4
106
524
AA1AD
NOMESCO Finland
CT of head and brain
1.6
9.4
311
2179
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
30.2
9.4
12
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
30.2
9.4
12
*
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
30.2
9.4
12
*
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
17.7
9.4
14
8
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.2
9.4
34
82
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.4
9.4
27
51
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
9.4
9
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
9.4
9
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
9.4
9
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
9.4
9
*
2112X
ICD-9 Finland
Benign neoplasm of other parts of digestive system, Duodenum, jejunum and ileum[NEOPLASMA BENIGNUM ALIUD INTESTINI TENUIS, DUOD INC]
+∞
9.4
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
9.4
9
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
9.4
9
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
9.4
9
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
9.4
9
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
9.4
9
*
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
+∞
9.4
9
*
K50.0
ICD-10 Finland
Crohn disease of small intestine
4.9
9.3
29
60
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
9.3
206
1300
WX882
NOMESCO Finland
High dependency care
3.4
9.3
43
129
R03DC03
ATC
montelukast; oral
1.7
9.2
187
1149
K92.0
ICD-10 Finland
Haematemesis
3.5
9.2
41
119
Z2446
NOMESCO Finland
Social worker
2.3
9.2
81
360
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
13.8
9.2
15
11
D70.82
ICD-10 Finland
Drug-induced neutropenia
13.8
9.2
15
11
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
13.8
9.2
15
11
R10.0
ICD-10 Finland
Acute abdomen
3.2
9.1
46
147
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
4.2
9.1
33
80
K25.3
ICD-10 Finland
Gastric ulcer, Acute without haemorrhage or perforation
8.4
9.1
19
23
B01AB04
ATC
dalteparin; parenteral
2.5
9.1
68
277
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
9.1
164
971
R03BA05
ATC
fluticasone; inhalant
1.7
9.1
213
1363
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
9.0
99
484
A03CA02
ATC
clidinium and psycholeptics; oral
2.2
9.0
92
435
A46
ICD-10 Finland
Erysipelas
1.8
8.9
176
1068
SPAT1262
SPAT
Handing over of treatment supplies
1.6
8.9
227
1486
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
2.6
8.9
65
262
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
24.2
8.9
12
5
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
24.2
8.9
12
5
SPAT1324
SPAT
Screening procedure
1.8
8.8
157
925
WX004
NOMESCO Finland
Patient-controlled sedation
10.8
8.8
16
15
C10AC01
ATC
colestyramine; oral
3.4
8.7
40
119
J01MA14
ATC
moxifloxacin; systemic
2.0
8.7
112
589
WZC00
SPAT
NA
2.7
8.7
59
228
J02AC01
ATC
fluconazole; systemic
1.5
8.7
430
3288
C03DA01
ATC
spironolactone; oral
1.8
8.6
152
891
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.5
8.6
39
115
XF402
NOMESCO Finland
ECG with work load test
1.8
8.6
162
971
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
8.6
178
1097
Z31.5
ICD-10 Finland
Genetic counselling
3.5
8.6
38
110
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.6
8.6
62
249
K50.9
ICD-10 Finland
Crohn disease, unspecified
5.0
8.5
26
53
ZX112
NOMESCO Finland
Subcutaneous
7.4
8.5
19
26
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
90.6
8.4
9
*
A10AE04
ATC
insulin glargine; parenteral
1.9
8.4
125
693
JFB30
NOMESCO Finland
Right hemicolectomy
7.9
8.4
18
23
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
8.3
8
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
8.3
8
*
JDH00
NOMESCO Finland
Duodenotomy
+∞
8.3
8
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
8.3
8
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
8.3
8
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
8.3
8
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
8.3
8
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
+∞
8.3
8
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.5
8.3
37
108
K26.3
ICD-10 Finland
Duodenal ulcer, acute without haemorrhage or perforation
8.6
8.3
17
20
R53
ICD-10 Finland
Malaise and fatigue
1.6
8.3
236
1588
J01AA02
ATC
doxycycline; systemic
1.5
8.3
942
8412
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
8.2
311
2238
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
14.6
8.2
13
9
K59.1
ICD-10 Finland
Functional diarrhoea
2.3
8.2
70
308
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
8.2
79
365
R07.3
ICD-10 Finland
Other chest pain
1.9
8.2
123
683
R01AD09
ATC
mometasone; nasal
1.4
8.2
476
3744
N03AX12
ATC
gabapentin; oral
1.7
8.1
194
1246
CBB30
NOMESCO Finland
Excision of lesion of eyelid
3.2
8.1
41
132
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
8.1
132
756
N05BA12
ATC
alprazolam; oral
1.9
8.1
123
688
K29.6
ICD-10 Finland
Other gastritis
4.5
8.1
27
61
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
2.3
8.0
70
309
N06AB10
ATC
escitalopram; oral
1.7
8.0
191
1227
ZXD20
NOMESCO Finland
Day surgery
1.8
8.0
151
904
J45.8
ICD-10 Finland
Mixed asthma
2.8
8.0
48
174
B82
ICPC
Anaemia other/unspecified
3.1
8.0
41
134
R18
ICD-10 Finland
Ascites
4.8
8.0
25
53
TK800
NOMESCO Finland
Hemodialysis
3.5
7.9
35
102
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
7.9
147
877
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
7.8
7.9
17
22
J01CA04
ATC
amoxicillin; systemic
1.4
7.8
912
8125
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
7.8
466
3672
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
9.5
7.8
15
16
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.7
7.8
50
188
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.7
7.8
50
188
A03DA02
ATC
pitofenone and analgesics; systemic
3.4
7.8
36
109
A07EC02
ATC
mesalazine; oral, rectal
2.4
7.7
63
270
K59.09
ICD-10 Finland
Constipation, unspecified
2.1
7.7
83
404
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
45.2
7.7
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
45.2
7.7
9
*
A07EA06
ATC
budesonide; oral, local oral
2.8
7.7
46
166
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
4.6
7.7
25
55
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
5.3
7.7
22
42
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.8
7.7
130
753
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.3
7.7
66
292
A03CA05
ATC
glycopyrronium bromide and psycholeptics; systemic
4.8
7.6
24
51
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
7.6
341
2536
R03BB04
ATC
tiotropium bromide; inhalant
1.8
7.6
131
760
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
7.6
73
340
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
25.1
7.6
10
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.0
7.5
93
481
R31
ICD-10 Finland
Unspecified haematuria
1.9
7.5
109
599
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
7.5
500
4019
K22.7
ICD-10 Finland
Barrett oesophagus
4.5
7.5
25
57
C08CA02
ATC
felodipine; oral
1.8
7.5
133
782
N06AX11
ATC
mirtazapine; oral
1.5
7.4
356
2684
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
7.4
212
1426
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.8
7.4
119
676
JKA20
NOMESCO Finland
Cholecystectomy
2.9
7.4
43
152
J01FF01
ATC
clindamycin; systemic
1.5
7.4
304
2223
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
6.0
7.4
19
32
R03AC03
ATC
terbutaline; inhalant
1.7
7.4
165
1040
B03XA02
ATC
darbepoetin alfa; parenteral
3.8
7.4
29
77
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.8
7.3
23
49
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.1
7.3
76
367
J45
ICD-10 Finland
Asthma
1.8
7.3
120
690
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
+∞
7.3
7
*
8140/3-C17.0
ICD-O-3
Adenocarcinoma, NOS, of duodenum
+∞
7.3
7
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
7.3
7
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
7.3
7
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
7.3
7
*
JA3CT
NOMESCO Finland
Cathetrisation of abdominal cavity with CT guidance
+∞
7.3
7
*
JDE00
NOMESCO Finland
Gastrojejunostomy
+∞
7.3
7
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
7.3
7
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
7.3
7
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
7.3
7
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
7.3
7
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.3
7
*
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
+∞
7.3
7
*
K55.8
ICD-10 Finland
Other vascular disorders of intestine
9.4
7.3
14
15
L57.0
ICD-10 Finland
Actinic keratosis
2.0
7.2
95
505
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
5.8
7.2
19
33
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
4.7
7.2
23
50
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.3
7.2
62
272
205
Kela drug reimbursment
Chronic hypertension
1.4
7.2
377
2889
E0000UV
ATC
NA
1.4
7.2
416
3253
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
30.2
7.1
9
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
30.2
7.1
9
*
K85.8
ICD-10 Finland
Other acute pancreatitis
8.0
7.1
15
19
N05BA04
ATC
oxazepam; oral
1.5
7.1
272
1955
R06AE07
ATC
cetirizine; oral
1.4
7.1
454
3609
Z12.4
ICD-10 Finland
Special screening examination for neoplasm of cervix
3.8
7.1
28
75
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
7.1
133
796
L02AE03
ATC
goserelin; implant
8.8
7.0
14
16
SPAT1263
SPAT
Sampling
1.4
7.0
486
3913
R02
ICPC
Shortness of breath/dyspnoea
1.7
7.0
149
925
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.3
7.0
33
102
G47.3
ICD-10 Finland
Sleep apnoea
1.5
6.9
244
1723
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
6.4
6.9
17
27
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
6.9
305
2258
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
3.0
6.9
38
131
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
4.3
6.9
24
57
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
6.9
151
946
S29
ICPC
Skin symptom/complaint other
1.6
6.9
193
1289
A02BX02
ATC
sucralfate; oral
2.3
6.9
58
255
C07AB02
ATC
metoprolol; systemic
1.5
6.8
273
1978
R42
ICD-10 Finland
Dizziness and giddiness
1.5
6.8
270
1953
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.5
6.8
22
49
K22.2
ICD-10 Finland
Oesophageal obstruction
6.1
6.8
17
28
ZX114
NOMESCO Finland
Intramuscular
5.7
6.8
18
32
N06AX16
ATC
venlafaxine; oral
1.7
6.8
127
760
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
40.2
6.8
8
*
TQW20
NOMESCO Finland
Tatoe
40.2
6.8
8
*
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
6.7
364
2802
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.6
6.7
163
1049
M54.5
ICD-10 Finland
Low back pain
1.4
6.7
355
2720
JDH25
NOMESCO Finland
Other endoscopic haemostatic procedure in duodenum
22.6
6.7
9
*
6402
FHL
Small bowel resection
22.6
6.7
9
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.9
6.7
20
41
A01
ICPC
Pain general/multiple sites
1.9
6.7
96
527
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.5
6.7
50
206
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
6.6
64
299
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
6.6
78
399
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
6.6
99
551
B01AA03
ATC
warfarin; systemic
1.5
6.6
270
1970
R03BA02
ATC
budesonide; inhalant
1.6
6.6
201
1371
L04AX01
ATC
azathioprine; systemic
2.4
6.5
55
239
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
4.8
6.5
20
42
JFB20
NOMESCO Finland
Ileocaecal resection
10.1
6.5
12
12
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
6.5
93
509
KCD02
NOMESCO Finland
Transurethral resection of bladder
6.9
6.5
15
22
GD1AD
NOMESCO Finland
Thorax CT examination
2.6
6.5
44
173
K50.8
ICD-10 Finland
Other Crohn disease
4.5
6.5
21
47
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.2
6.5
65
309
JFA25
NOMESCO Finland
Endoscopic contact coagulation in small intestine
70.1
6.4
7
*
A10BA02
ATC
metformin; oral
1.4
6.4
345
2648
J01EA01
ATC
trimethoprim; systemic
1.5
6.4
280
2066
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
6.3
122
738
R05
ICD-10 Finland
Cough
1.5
6.3
226
1597
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.2
6.3
59
270
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
6.3
204
1410
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
4.2
6.3
22
53
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
5.5
6.3
17
31
JFA55
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in colon
11.1
6.3
11
10
SPAT1336
SPAT
Request for examination
2.4
6.3
48
201
S22.3
ICD-10 Finland
Fracture of rib
2.0
6.3
79
413
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
6.3
119
714
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
6.3
6
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
6.3
6
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
6.3
6
*
1CD02
NOMESCO Finland
NA
+∞
6.3
6
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
6.3
6
*
L02BX02
ATC
degarelix; parenteral
+∞
6.3
6
*
JKC50
NOMESCO Finland
Excision of papilla of Vater and anastomosis of bile duct to duodenum or jejunum
+∞
6.3
6
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
6.3
6
*
8263/2-C17.0
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of duodenum
+∞
6.3
6
*
8240/3-C17.0
ICD-O-3
Neuroendocrine tumor, NOS, of duodenum
+∞
6.3
6
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
6.3
6
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
6.3
6
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
6.3
6
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
6.3
6
*
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
+∞
6.3
6
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
6.3
6
*
R60.9
ICD-10 Finland
Oedema, unspecified
2.2
6.2
61
286
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.2
6.2
30
95
K57
ICD-10 Finland
Diverticular disease of intestine
2.9
6.2
36
128
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
3.6
6.2
26
74
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
3.9
6.2
23
59
D01
ICPC
Abdominal pain/cramps general
1.7
6.2
112
665
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.6
6.2
42
166
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
5.4
6.2
17
32
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.1
6.1
63
303
J01DA01
ATC
[U] cefalexin; systemic
1.3
6.1
707
6142
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
3.0
6.1
32
108
R03AC13
ATC
formoterol; inhalant
2.1
6.1
65
318
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.1
6.1
61
292
R06AX22
ATC
ebastine; oral
1.6
6.1
173
1159
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
6.1
86
471
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
3.1
6.1
31
103
K85
ICD-10 Finland
Acute pancreatitis
3.4
6.1
27
81
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
6.7
6.0
14
21
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.2
6.0
57
264
N02AA01
ATC
morphine; systemic, rectal
5.2
6.0
17
33
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
6.0
373
2935
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
2.5
6.0
43
174
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
361
632
7.38
208.31
3.6
1.4
ug/l
7.9
3.7
0.71
297
481
(40768797) Stomach Pathology biopsy report
571
1577
5.47
202.14
2.1
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
187
231
9.21
144.04
3.6
1.9
u/ml
43.7
132.5
0.60
152
179
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
979
5400
3.79
114.21
9.2
3.8
umol/l
12.9
11.8
0.61
954
5042
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
304
833
4.40
101.47
2.9
1.9
g/l
0.2
0.2
2.77
282
750
(4035726)
172
306
6.28
94.46
1.4
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
867
4772
3.19
94.16
7.9
3.7
g/l
34.5
35.5
5.92
827
4369
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
332
1085
3.71
85.40
4.1
2.2
umol/l
10.1
7.8
0.60
300
946
(3044640) Blood type and Crossmatch panel - Blood
633
3127
2.89
79.83
3.9
2.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
388
1457
3.31
79.66
3.9
2.6
%
19.3
22.8
5.00
336
1227
(3032080) INR in Blood by Coagulation assay
829
4745
2.87
78.44
12.1
10.5
inr
1.3
1.3
0.29
162
1337
(3022948) Iron [Moles/volume] in Serum or Plasma
428
1731
3.13
77.21
3.8
2.4
umol/l
11.1
13.1
7.41
404
1593
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
287
913
3.71
76.19
3.7
2.1
u/l
52.7
40.9
0.45
262
757
(3004789) Transferrin [Mass/volume] in Serum or Plasma
401
1579
3.17
75.55
3.8
2.5
g/l
2.4
2.3
0.59
378
1464
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
593
2910
2.82
74.56
3.3
2.2
mg/l
3.6
3.0
5.41
531
2441
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
666
3505
2.74
72.52
4.3
2.3
u/l
57.4
58.3
0.21
638
3204
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
628
3296
2.66
67.52
4.7
2.6
u/l
32.8
32.6
0.05
600
3112
(3014576) Chloride [Moles/volume] in Serum or Plasma
353
1380
3.09
66.38
8.4
5.7
mmol/l
104.3
104.1
0.38
348
1343
(3013650) Neutrophils [#/volume] in Blood by Automated count
932
5979
2.72
65.43
11.0
6.4
e9/l
4.4
4.3
0.50
833
5128
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1174
8571
3.46
63.45
12.1
5.4
u/l
88.1
76.2
5.52
1139
7900
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
797
4798
2.56
62.90
6.4
3.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
897
5749
2.60
61.34
9.3
5.5
mmol/l
1.2
1.2
2.43
812
4838
(3013826) Glucose [Moles/volume] in Serum or Plasma
993
6745
2.68
59.09
6.9
4.2
mmol/l
6.8
6.8
0.07
948
6314
(3033658) Prothrombin time (PT) actual/Normal
518
2636
2.54
57.29
6.7
3.4
%
86.4
87.0
0.18
507
2560
(3023368) Bacteria identified in Blood by Culture
560
2964
2.50
56.81
5.8
4.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
373
1641
2.74
55.25
3.9
2.6
mmol/l
0.8
0.8
1.77
346
1504
(3001604) Monocytes [#/volume] in Blood
841
5393
2.43
54.85
7.3
5.4
e9/l
0.6
0.6
0.07
736
4599
(3030467) Casts [#/volume] in Urine by Automated count
569
3076
2.44
54.62
4.3
3.0
e6/l
0.7
0.4
0.60
461
2318
(3019069) Monocytes/100 leukocytes in Blood
800
5027
2.40
54.51
7.8
5.9
%
8.6
8.8
0.82
758
4650
(3006315) Basophils [#/volume] in Blood
842
5420
2.42
54.17
7.3
5.5
e9/l
0.0
0.0
0.10
737
4630
(40768804) Tissue Pathology biopsy report
628
3558
2.40
54.12
2.5
1.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
852
5528
2.41
53.60
7.4
5.5
e9/l
1.8
1.9
0.31
760
4799
(3006504) Eosinophils/100 leukocytes in Blood
795
5006
2.38
53.56
7.4
5.7
%
2.9
3.0
0.08
751
4610
(36304419) Bacteria [Presence] in Urine
554
2981
2.43
53.48
4.2
2.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
281
1080
3.01
53.40
1.4
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
859
5604
2.41
53.21
7.7
5.6
e9/l
0.2
0.2
0.22
766
4867
(3002030) Lymphocytes/100 leukocytes in Blood
806
5123
2.38
52.89
7.6
5.8
%
26.2
27.3
1.87
761
4715
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
84
129
6.87
52.75
3.1
1.7
u/ml
550.0
48.5
0.80
72
115
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
478
2424
2.49
52.38
3.7
2.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
126
285
4.76
52.33
1.5
1.5
ug/g
225.8
300.4
3.80
90
167
(3018010) Neutrophils/100 leukocytes in Blood
799
5081
2.36
52.05
7.4
5.6
%
58.5
57.8
1.09
751
4695
(3001122) Ferritin [Mass/volume] in Serum or Plasma
731
4514
2.31
50.50
4.8
2.7
ug/l
105.6
129.4
2.81
681
4109
(3002582) Erythrocytes [#/volume] in Urine
591
3343
2.34
50.14
4.4
3.1
e6/l
28.5
98.3
2.14
491
2555
(3022096) Basophils/100 leukocytes in Blood
768
4873
2.30
49.31
7.4
5.7
%
0.7
0.7
0.07
726
4497
(40758558) Short blood count panel - Blood
479
2504
2.40
48.37
8.3
4.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
311
1338
2.71
47.36
2.8
2.2
%
1.9
1.8
0.76
284
1171
(3018095) Leukocytes [#/volume] in Urine
655
3937
2.26
47.33
5.0
3.5
e6/l
93.3
117.7
0.24
509
2769
(3026782) Osmolality of Urine
433
2182
2.43
47.30
3.2
2.6
mosm/kgh2o
519.9
545.1
1.47
370
1819
(3002032) Base excess in Venous blood by calculation
273
1129
2.77
44.68
5.1
3.1
mmol/l
1.8
2.1
0.75
233
906
(3003458) Phosphate [Moles/volume] in Serum or Plasma
327
1481
2.58
44.61
7.3
4.8
mmol/l
1.0
1.0
0.64
301
1347
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
384
1907
2.40
42.70
3.3
2.6
e6/l
2.7
1.3
0.85
237
1091
(3000991) Gas panel - Venous blood
234
913
2.88
42.62
8.0
6.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
604
3624
2.18
42.58
6.7
5.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
204
741
3.06
42.23
2.2
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
444
2375
2.28
41.34
3.2
2.4
e6/l
4.7
5.7
1.02
394
2057
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
163
528
3.37
40.81
1.7
1.6
g/l
1.6
1.5
0.38
138
455
(3002256) Pathology report gross observation
215
820
2.92
40.73
1.3
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
772
5209
2.09
38.79
8.6
5.0
mmol/l
1.2
1.2
4.59
721
4596
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
351
1741
2.36
38.65
3.6
2.7
e6/l
2.8
2.6
0.07
208
928
(3021589) Normoblasts [#/volume] in Blood
727
4802
2.08
38.65
12.7
8.7
e9/l
0.0
0.0
0.50
607
3890
(3024354) Oxygen [Partial pressure] in Venous blood
231
941
2.75
38.54
4.3
2.6
kpa
4.5
4.6
0.21
226
905
(3020779) Urea [Moles/volume] in Serum or Plasma
235
971
2.71
38.11
9.3
6.7
mmol/l
10.7
10.7
0.01
225
920
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
261
1138
2.59
37.98
4.3
3.2
u/l
231.4
238.4
0.65
245
1062
(3027801) Oxygen [Partial pressure] in Arterial blood
287
1311
2.50
37.86
7.4
6.2
kpa
11.8
11.6
0.37
271
1252
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
287
1311
2.50
37.86
7.4
6.3
kpa
5.1
5.1
0.10
270
1254
(3003396) Base excess in Arterial blood by calculation
285
1299
2.50
37.77
7.4
6.3
mmol/l
1.0
1.3
0.55
232
1005
(3018418) pH of Serum or Plasma
555
3343
2.10
37.52
5.8
3.3
ph
7.4
7.4
0.78
58
573
(3018677) aPTT in Platelet poor plasma by Coagulation assay
349
1748
2.33
37.43
2.6
2.0
s
30.7
29.8
1.17
342
1683
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
773
5266
2.06
37.27
2.5
2.0
pmol/l
90.1
94.5
1.82
442
2615
(3015377) Calcium [Moles/volume] in Serum or Plasma
597
3710
2.07
36.97
3.5
2.1
mmol/l
2.3
2.4
2.39
531
3055
(3031040) Bacteria [#/volume] in Urine by Automated count
994
7459
2.18
36.67
6.3
4.7
e6/l
97.3
1887.3
—
9
116
(3042936) Bacteria identified in Isolate by Culture
310
1505
2.37
35.53
2.4
2.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
425
2386
2.13
33.93
4.9
3.9
ng/l
102.7
429.1
6.47
351
1981
(3048689) Calprotectin [Mass/mass] in Stool
256
1181
2.43
32.66
2.3
2.2
ug/g
155.0
148.0
0.13
216
924
(3016502) Oxygen saturation in Arterial blood
255
1177
2.43
32.49
7.7
6.5
%
95.4
95.0
0.38
245
1133
(3023520) Reticulocytes [#/volume] in Blood
228
1006
2.52
31.99
2.4
2.3
e9/l
72.7
69.4
0.50
170
772
(3014111) Lactate [Moles/volume] in Serum or Plasma
221
963
2.54
31.83
6.7
5.5
mmol/l
1.3
1.4
0.67
214
929
(3002173) Hemoglobin [Mass/volume] in Arterial blood
236
1072
2.45
31.05
8.0
6.8
g/l
116.6
121.3
2.91
226
1034
(3005719) IgG [Mass/volume] in Serum or Plasma
180
727
2.70
30.18
2.1
2.2
g/l
10.1
10.8
1.02
166
663
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
901
6826
1.92
28.27
4.5
3.0
u/l
65.7
47.4
4.11
845
6237
(3013707) Erythrocyte sedimentation rate by Westergren method
1067
8575
2.07
28.03
5.4
4.3
mm/h
15.2
12.6
5.36
1002
7903
(3019309) Folate [Moles/volume] in Red Blood Cells
415
2466
1.98
27.34
1.7
1.8
nmol/l
1138.8
1176.3
0.35
335
1835
(3028026) IgM [Mass/volume] in Serum or Plasma
149
582
2.75
26.55
1.7
1.4
g/l
1.2
1.2
0.04
138
530
(3037467) Urinalysis macro (dipstick) panel - Urine
993
7859
1.94
26.19
5.6
4.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
547
3614
1.85
25.73
3.6
3.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
120
431
2.95
24.96
2.5
1.7
ug/l
3.9
1.7
0.93
101
376
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
389
2325
1.94
24.81
2.2
1.8
mg/l
1.2
1.3
0.44
312
1797
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
144
577
2.67
24.37
8.5
8.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
232
1156
2.21
24.22
3.5
3.2
ng/l
218.4
222.6
0.05
211
1059
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
252
1308
2.13
23.69
2.3
1.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
750
5565
1.76
23.00
4.6
3.8
estimate
0.0
0.0
0.00
84
965
(3009261) Glucose [Presence] in Urine by Test strip
759
5653
1.76
22.95
4.7
3.9
estimate
0.0
0.0
1.08
85
943
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
62
153
4.20
22.92
1.2
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
472
3065
1.82
22.87
1.8
1.5
nmol/l
21.4
20.8
0.22
424
2554
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
250
1312
2.11
22.77
2.3
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
242
1262
2.11
22.38
2.2
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
750
5592
1.75
22.36
7.0
5.1
estimate
0.0
0.0
0.50
86
959
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1269
11210
2.61
22.22
29.2
13.3
mg/l
25.6
23.5
1.56
1122
8752
(3007164) IgA [Mass/volume] in Serum or Plasma
328
1913
1.94
22.16
1.5
1.3
g/l
2.7
2.6
0.37
198
1093
(3020630) Protein [Mass/volume] in Serum or Plasma
201
983
2.22
21.85
2.7
1.6
g/l
65.3
67.2
3.16
187
888
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
357
2156
1.88
21.63
3.4
2.2
mmol/l
2.5
2.5
1.54
316
1843
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
558
3861
1.75
21.43
3.5
3.1
ng/l
2014.2
1505.2
0.91
491
3309
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
664
4835
1.72
21.12
2.8
2.3
nmol/l
77.5
79.4
0.90
606
4208
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
317
1863
1.91
20.78
2.3
1.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
133
555
2.55
20.65
4.9
3.3
mmol/l
23.9
24.3
0.84
122
488
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
135
568
2.53
20.61
7.5
7.6
mmol/l
24.4
24.5
0.12
125
519
(3037522) Nuclear Ab [Titer] in Serum
264
1486
1.96
19.56
1.4
1.3
titre
392.4
615.5
1.93
63
356
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
83
278
3.11
19.47
3.2
2.1
%
92.7
89.4
0.53
77
262
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
192
967
2.14
19.27
5.1
3.7
ng/l
119.7
91.8
2.60
162
830
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
92
333
2.89
18.83
3.1
3.3
u/ml
0.3
0.4
0.58
58
200
(3014765) Yersinia sp identified in Stool by Organism specific culture
87
306
2.97
18.75
1.3
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
27
37
7.42
18.69
1.7
2.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
147
675
2.32
18.46
1.9
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
87
309
2.94
18.43
1.3
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
183
920
2.14
18.42
1.7
1.5
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
50
124
4.15
18.38
7.4
7.1
mg/l
11.0
12.4
0.97
45
115
(3025941) Bacteria identified in Stool by Culture
125
536
2.46
18.29
1.5
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
173
854
2.17
18.24
1.8
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
85
303
2.92
17.89
1.3
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
56
154
3.75
17.87
2.7
2.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
162
787
2.20
17.76
6.5
4.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
58
165
3.63
17.62
1.5
1.8
g/l
0.8
1.0
0.21
46
130
(3007566) Smooth muscle Ab [Titer] in Serum
81
284
2.97
17.56
1.3
1.2
titre
88.0
78.8
—
5
25
(3002385) Erythrocyte distribution width [Ratio]
1068
9078
1.78
17.44
35.7
16.0
%
14.3
13.7
16.81
1052
8842
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
53
145
3.76
17.04
5.2
5.7
iu/ml
115.3
429.8
—
10
21
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
139
646
2.28
16.94
2.9
2.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
348
2246
1.73
16.26
5.3
4.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
83
311
2.78
15.94
4.4
4.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
153
762
2.13
15.70
9.5
6.7
mmol/l
24.1
24.6
0.57
144
709
(3000330) Specific gravity of Urine by Test strip
134
635
2.23
15.57
4.7
3.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
26
42
6.29
15.50
1.8
2.2
%
15.1
12.1
0.43
13
20
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
71
249
2.95
15.40
6.5
2.3
%
224.6
189.2
1.88
66
235
(3026493) Urate [Moles/volume] in Serum or Plasma
439
3055
1.64
15.28
3.5
2.4
umol/l
3164.6
6495.4
1.11
388
2591
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1030
8788
1.68
15.18
4.8
4.0
pmol/l
14.9
15.0
0.63
953
7915
(3021879) Hepatitis B virus core Ab [Presence] in Serum
113
510
2.32
14.73
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
67
234
2.96
14.64
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
67
234
2.96
14.64
1.4
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
64
218
3.03
14.61
4.5
2.5
umol/l
36.5
33.7
0.30
52
189
(3036489) Thrombin time
90
369
2.54
14.47
3.2
1.9
s
22.0
21.1
0.97
83
323
(3011412) CD3 cells [#/volume] in Blood
29
56
5.27
14.41
2.1
2.1
e9/l
1.1
1.2
0.04
19
28
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
618
4717
1.56
14.32
4.9
3.9
ng/l
40.8
74.6
0.95
465
3445
(4094501)
82
325
2.62
14.13
1.2
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
194
1097
1.89
13.88
1.9
1.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1068
9284
1.66
13.70
39.9
17.7
g/l
330.3
332.1
7.79
1061
9212
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
44
124
3.63
13.59
1.1
1.0
g/l
1.5
1.5
0.51
39
109
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
86
357
2.50
13.48
2.6
1.5
mg/l
41.4
50.8
0.23
78
286
(3034860) Kappa light chains.free [Mass/volume] in Serum
86
358
2.50
13.40
2.6
1.5
mg/l
102.0
44.8
0.67
77
287
(3052851) Hemolysis interference index of Serum or Plasma
81
328
2.56
13.37
3.6
3.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
376
2595
1.62
13.19
5.0
4.3
kg/l
1.0
1.0
2.50
117
382
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
518
3863
1.55
12.95
2.1
2.2
u/l
219.5
225.2
0.03
496
3604
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
337
2283
1.63
12.68
1.3
1.3
u/ml
2.0
1.7
0.10
90
613
(3004716) Salmonella sp identified in Stool by Organism specific culture
101
464
2.27
12.63
1.4
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
89
388
2.38
12.56
1.6
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1116
9896
1.66
12.30
33.1
14.8
%
37.6
39.4
6.07
708
6455
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
223
1366
1.75
12.21
1.5
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
49
159
3.16
12.18
1.2
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
263
1689
1.69
12.13
33.7
29.4
inr
1.2
1.4
0.75
19
233
(3007930) Methemoglobin/Hemoglobin.total in Blood
104
493
2.20
12.06
6.4
4.7
%
0.9
0.9
0.10
98
468
(3011397) Hemoglobin [Presence] in Urine by Test strip
388
2749
1.57
12.01
4.3
3.8
—
—
—
0
0
(3036603) Volume of Urine
28
63
4.52
11.69
1.5
1.4
ml
1794.2
1946.5
0.37
12
14
(40760888) Immunoglobulin light chains.free panel - Serum
67
265
2.61
11.62
2.0
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
104
502
2.16
11.53
6.3
4.6
%
1.6
1.6
0.20
98
476
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
15
18
8.41
11.50
1.3
2.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
153
857
1.88
11.21
2.0
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
18
28
6.50
11.10
3.4
2.0
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
16
22
7.35
11.00
1.7
1.7
g/l
9.0
11.9
0.61
11
15
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
66
270
2.52
10.70
1.6
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
40
125
3.27
10.59
5.3
3.4
—
—
—
0
0
(3044889) 12 lead EKG panel
957
8297
1.50
10.57
5.0
4.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
137
755
1.90
10.54
1.2
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
99
490
2.10
10.30
2.3
1.4
g/l
3.8
3.9
0.21
64
351
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
99
490
2.10
10.30
2.3
1.4
g/l
7.3
7.5
0.61
67
361
(3019550) Sodium [Moles/volume] in Serum or Plasma
1282
11965
1.99
10.12
33.7
16.1
mmol/l
139.4
139.8
5.36
1264
11639
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
94
461
2.11
10.02
2.3
1.4
g/l
9.6
10.6
1.21
79
387
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
490
2.08
9.93
2.3
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
168
1005
1.76
9.91
2.4
1.8
nmol/l
346.4
368.4
0.67
153
905
(21494890) Protein electrophoresis panel - 24 hour Urine
33
96
3.50
9.78
2.1
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1283
12000
1.97
9.72
33.9
16.2
mmol/l
4.0
4.0
2.79
1262
11653
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
59
242
2.50
9.54
1.4
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
47
172
2.79
9.51
1.4
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
147
856
1.80
9.49
4.6
3.9
%
1.1
0.7
0.24
34
190
(44790047)
35
108
3.30
9.48
1.7
1.5
—
—
—
0
0
(44790048)
35
108
3.30
9.48
1.7
1.5
—
—
—
0
0
(44806118)
35
108
3.30
9.48
1.7
1.5
—
—
—
0
0
(44790049)
35
108
3.30
9.48
1.7
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
543
4292
1.44
9.35
5.4
4.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
72
329
2.25
9.16
1.4
1.6
g/l
1.2
1.2
0.18
64
313
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
71
323
2.26
9.13
1.4
1.6
g/l
0.2
0.2
0.38
64
310
(4062490)
34
106
3.26
9.07
1.2
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
41
143
2.92
9.07
1.3
1.4
u/ml
127.9
113.1
0.80
12
25
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
73
338
2.22
9.01
2.8
2.3
ug/min
139.3
91.6
0.27
56
203
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
12
9.23
8.98
1.5
3.8
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
34
107
3.23
8.94
1.2
1.4
g/l
3.0
2.8
0.21
26
78
(3027135) IgG subclass 1 [Mass/volume] in Serum
34
107
3.23
8.94
1.2
1.4
g/l
6.7
6.9
0.10
26
80
(3024139) IgG subclass 3 [Mass/volume] in Serum
34
107
3.23
8.94
1.2
1.4
g/l
0.5
0.4
0.46
26
79
(3039162) Centromere protein B Ab [Units/volume] in Serum
38
128
3.02
8.93
1.2
1.3
u/ml
89.7
66.1
—
5
7
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
71
327
2.23
8.88
1.4
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
53
214
2.54
8.87
1.5
1.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
19
39
4.93
8.85
5.8
1.1
u/ml
385.2
37.3
—
7
10
(3000494) Fungus identified in Specimen by Culture
202
1309
1.64
8.83
1.8
1.4
—
—
—
0
0
(3020891) Body temperature
95
491
2.00
8.82
8.1
4.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
276
1930
1.54
8.72
1.3
1.3
iu/ml
37.0
39.6
0.11
80
617
(3013512) EKG study
465
3609
1.43
8.69
5.4
4.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
58
247
2.41
8.68
1.2
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
30
90
3.39
8.51
1.2
1.3
titre
350.0
155.0
—
5
18
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
126
724
1.81
8.50
1.9
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
51
207
2.52
8.46
1.6
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
42
155
2.76
8.40
1.5
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
52
214
2.49
8.38
1.6
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
38
133
2.91
8.37
1.1
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
30
92
3.31
8.23
1.5
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
13
9
14.56
8.20
7.5
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
14
23
6.14
8.19
2.9
2.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
21
51
4.17
8.01
1.5
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
263
1855
1.52
7.92
1.3
1.2
u/ml
27.8
11.8
0.48
102
711
(4010399)
143
871
1.72
7.90
1.5
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
136
818
1.73
7.85
4.7
4.0
%
0.2
0.1
0.31
32
170
(40761511) CBC panel - Blood by Automated count
1244
11642
1.69
7.81
28.1
13.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
184
1203
1.61
7.73
2.7
2.5
ug/l
5.3
7.4
1.93
164
1050
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
72
353
2.10
7.73
2.3
3.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
378
2877
1.43
7.70
4.7
3.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
19
44
4.36
7.69
2.3
1.6
e9/l
0.2
0.2
0.02
14
38
(4281824)
21
53
4.01
7.63
1.5
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
27
82
3.34
7.54
1.1
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
19
45
4.27
7.48
2.3
1.6
e6/l
420.5
468.9
0.18
13
38
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
61
284
2.20
7.47
1.9
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1149
10583
1.51
7.44
6.0
4.8
mu/l
1.9
2.1
0.90
1081
9564
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
41
160
2.61
7.40
1.3
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
20
50
4.04
7.36
2.0
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
101
568
1.84
7.32
3.1
2.5
e6/l
0.2
0.2
0.22
101
551
(40768793) Breast Pathology biopsy report
27
84
3.26
7.27
1.3
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
12
19
6.36
7.25
1.7
2.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
19
47
4.08
7.09
2.1
2.4
u/ml
547.1
1090.7
1.21
19
47
(3051651) Icteric interference index of Serum or Plasma
19
47
4.08
7.09
3.9
3.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
62
297
2.14
7.09
1.5
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
129
787
1.70
7.08
4.1
4.0
%
0.0
0.6
0.49
23
156
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
15
31
4.88
6.94
3.5
2.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
692
5893
1.35
6.91
2.9
2.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
84
455
1.90
6.85
2.5
1.4
g/l
3.3
3.1
0.84
64
356
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
146
930
1.64
6.81
2.7
2.3
ml/min/173m2
53.8
64.1
2.84
76
380
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
359
2759
1.41
6.80
1.8
1.7
pmol/l
31013124.8
29676131.0
0.01
316
2251
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
30
104
2.93
6.76
1.1
1.1
u/l
53.0
53.2
0.01
21
75
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
77
408
1.94
6.71
2.5
1.4
g/l
0.9
0.5
0.74
66
350
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
38
151
2.56
6.64
1.0
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
18
45
4.04
6.63
2.6
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
30
106
2.87
6.55
2.5
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
13
25
5.24
6.49
1.0
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
37
147
2.56
6.47
1.3
1.2
u/ml
2.1
2.2
0.07
12
46
(3000492) Spirometry study
146
944
1.61
6.41
1.6
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
160
2.48
6.39
1.5
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1274
12095
1.68
6.32
17.1
9.4
u/l
26.3
25.1
1.76
1254
11539
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
27
93
2.94
6.18
2.3
2.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
17
43
3.99
6.17
1.4
1.8
u/l
227.5
196.8
0.31
17
43
(3037756) Immunofixation for Serum or Plasma
48
220
2.22
6.15
1.5
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
81
451
1.85
6.09
1.3
1.2
u/ml
4.7
0.5
—
7
37
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
65
338
1.97
6.00
2.6
1.4
g/l
0.0
0.0
0.00
60
311
(3035637) Corticotropin [Mass/volume] in Plasma
27
95
2.88
5.96
1.8
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
45
204
2.25
5.93
1.8
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
68
362
1.92
5.87
2.5
1.4
g/l
0.0
0.0
0.59
63
331
(3032773) Endomysium IgG Ab [Titer] in Serum
25
85
2.98
5.86
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
36
149
2.45
5.81
1.5
1.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
65
342
1.95
5.81
2.6
1.4
g/l
0.0
0.0
0.00
60
312
(40768443) Skin Pathology biopsy report
77
430
1.84
5.75
1.2
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
12
24
5.04
5.75
1.1
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
12
24
5.04
5.75
2.9
4.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
21
65
3.27
5.74
1.5
1.5
u/l
3.4
7.9
0.69
12
30
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
36
151
2.42
5.66
1.5
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
482
3977
1.33
5.62
3.3
3.2
mg/l
1144.2
273.7
1.70
322
2473
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
34
140
2.46
5.56
1.2
1.2
u/ml
10.3
5.9
0.22
12
65
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
31
122
2.58
5.56
1.4
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
70
385
1.86
5.50
2.5
1.4
g/l
36.8
37.8
0.69
61
325
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
135
893
1.57
5.40
4.0
3.0
mmol/l
1.2
1.2
0.27
126
753
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
50
247
2.06
5.35
1.4
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
35
150
2.37
5.27
1.0
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
99
611
1.67
5.25
2.9
2.9
pmol/l
4.2
4.5
2.86
90
520
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
19
59
3.25
5.18
1.1
1.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
61
328
1.90
5.15
1.4
1.6
iu/ml
0.1
0.1
0.08
15
71
(3023199) Leukocytes [#/volume] in Pleural fluid
29
115
2.55
5.14
1.7
1.5
e6/l
1310.7
1709.2
0.43
23
82
(3020874) Milk IgE Ab [Units/volume] in Serum
13
31
4.22
5.09
1.2
1.0
u/ml
0.4
2.7
—
7
10
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
50
252
2.02
5.08
1.2
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
18
55
3.30
5.03
1.1
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
50
254
2.00
4.98
2.7
2.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
499
4193
1.30
4.95
3.9
3.9
mg/mmol
20.8
7.5
3.15
329
2626
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1143
10717
1.38
4.93
24.4
12.2
ml/min/173m2
74.9
75.9
0.82
1013
8613
(44813793)
19
61
3.14
4.92
1.2
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
44
215
2.08
4.87
1.1
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
50
259
1.97
4.73
9.2
6.6
mmol/l
11.8
11.0
0.74
44
236
(3018572) Chloride [Moles/volume] in Blood
50
259
1.97
4.73
9.2
6.6
mmol/l
104.9
105.4
0.25
44
236
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
38
3.71
4.65
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
22
80
2.78
4.62
1.5
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
141
2.30
4.56
1.5
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
326
2609
1.33
4.56
1.5
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
25
98
2.58
4.56
1.1
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
78
471
1.70
4.52
1.7
1.9
u/l
37.5
38.8
0.19
62
405
(3028308) Erythrocytes [#/volume] in Pleural fluid
26
105
2.50
4.48
1.5
1.6
e6/l
125662.6
88239.1
0.17
16
60
(3004809) Band form neutrophils/100 leukocytes in Blood
29
124
2.37
4.43
4.7
3.0
%
0.8
1.4
0.73
21
93
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
13
35
3.74
4.37
1.2
1.1
g/l
0.3
0.3
—
8
23
(40761535) Cells panel - Urine sediment
147
1039
1.46
4.33
4.6
3.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
117
790
1.53
4.30
4.2
3.8
%
0.5
0.5
0.15
20
145
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
47
249
1.92
4.20
1.5
1.5
nmol/l
0.8
0.8
0.04
42
202
(4306422)
30
136
2.23
4.04
1.2
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
7
10.04
4.01
1.9
3.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
14
6.46
3.98
1.0
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
100
665
1.54
3.96
1.2
1.3
—
53.0
—
0
25
(36660697) Celiac disease serology panel - Serum
122
847
1.48
3.94
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
30
138
2.20
3.91
1.1
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
17
59
2.90
3.90
1.2
1.1
u/l
19.3
18.0
0.08
17
50
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
48
263
1.85
3.90
4.1
2.9
mg/l
1.7
1.6
0.37
42
236
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
29
132
2.22
3.88
1.5
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
40
207
1.96
3.85
3.1
2.6
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
9
15
6.03
3.82
1.9
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
43
229
1.91
3.81
1.8
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
52
296
1.79
3.75
3.3
3.4
nmol/l
0.8
0.8
0.14
40
226
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
20
78
2.59
3.72
1.4
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
20
78
2.59
3.72
1.4
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
20
78
2.59
3.72
1.4
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
8
12
6.70
3.67
1.1
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
156
1152
1.40
3.63
4.3
3.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1289
12465
1.51
3.61
43.5
19.7
e9/l
248.0
247.1
0.17
1264
12074
(21494755) Public health laboratory ask at order entry panel
35
651
0.53
3.58
1.3
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
1289
12467
1.50
3.58
43.3
19.6
fl
91.1
91.5
1.84
1277
12231
(3035941) MCH [Entitic mass]
1289
12468
1.50
3.57
43.3
19.6
pg
30.2
30.4
5.26
1277
12232
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
9
7.81
3.56
1.4
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1289
12469
1.50
3.56
43.5
19.7
e9/l
7.0
6.7
3.97
1257
12032
(3026361) Erythrocytes [#/volume] in Blood
1289
12469
1.50
3.56
43.5
19.7
e12/l
4.3
4.5
17.98
1257
12030
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
44
242
1.85
3.55
1.3
1.2
u/ml
10.6
6.4
—
5
20
(3017732) Neutrophils [#/volume] in Blood
104
716
1.49
3.52
2.3
2.8
e9/l
4.2
4.2
0.01
71
516
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
142
1038
1.41
3.51
2.1
1.7
%
1.7
1.5
1.26
118
872
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
23
99
2.35
3.51
1.5
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
61
371
1.67
3.50
8.5
5.9
mmol/l
1.6
1.3
1.06
52
332
(3000963) Hemoglobin [Mass/volume] in Blood
1289
12473
1.50
3.50
43.8
19.8
g/l
129.0
135.4
35.95
1277
12236
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
17
63
2.72
3.49
1.2
1.1
u/l
74.5
88.2
0.42
17
55
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
52
303
1.74
3.48
1.3
1.2
u/ml
1.8
3.0
—
7
31
(3047189) Immunofixation for 24 hour Urine
11
31
3.57
3.48
2.5
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31
152
2.06
3.47
1.1
1.2
u/ml
279.6
248.4
0.27
20
94
(40768806) Pleura Pathology biopsy report
20
81
2.49
3.47
1.4
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
32
160
2.02
3.41
1.1
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
105
730
1.47
3.40
3.9
3.5
kpa
5.1
5.2
0.25
97
677
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
100
690
1.48
3.36
3.9
3.5
mmol/l
1.8
1.9
0.05
71
512
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
53
2.85
3.36
1.2
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
16
59
2.73
3.33
1.1
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
76
496
1.56
3.31
1.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
18
71
2.56
3.30
2.1
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
23
102
2.28
3.30
3.9
3.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
28
135
2.10
3.29
1.2
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
52
309
1.71
3.27
1.3
1.2
u/ml
2.2
8.3
—
7
56
(3003181) Sodium [Moles/volume] in Urine
41
227
1.83
3.27
1.5
1.3
mmol/l
61.4
64.5
0.19
27
180
(3003888) Timothy IgE Ab [Units/volume] in Serum
24
110
2.20
3.20
1.2
1.0
u/ml
1.0
3.7
1.68
11
49
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
91
2.33
3.18
1.5
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
137
2.07
3.18
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
85
2.37
3.16
1.3
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
16
61
2.64
3.14
2.3
2.3
—
—
—
0
0
(3009343) pH of Capillary blood
102
719
1.45
3.10
3.9
3.5
ph
7.4
7.4
—
6
85
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1151
10980
1.29
3.09
8.1
6.4
mmol/mol
41.3
40.6
1.49
1085
10101
(3000093) Morphology [Interpretation] in Blood Narrative
22
100
2.22
3.00
1.1
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
21
4.31
2.99
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
51
2.76
2.99
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
51
2.76
2.99
1.1
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
5
10.03
2.98
1.4
1.0
—
—
—
0
0
(4268621)
21
94
2.25
2.97
2.0
2.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
30
3.35
2.91
1.3
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
50
305
1.66
2.89
2.1
1.6
e6/l
11336.5
13044.5
0.18
40
228
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
15
58
2.60
2.88
1.4
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
58
2.60
2.88
1.4
1.2
—
—
—
0
0
(4211845)
16
64
2.52
2.87
4.4
3.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
28
143
1.98
2.86
1.3
1.2
nmol/l
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
21
96
2.21
2.84
1.5
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
465
4079
1.21
2.81
3.2
3.1
mmol/l
7.1
7.3
0.33
389
3420
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
18
4.46
2.79
1.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
59
2.56
2.79
2.3
2.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
42
687
0.60
2.77
2.2
1.8
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
7
14
5.02
2.73
1.6
1.4
umol/l
50.4
47.7
—
7
14
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
10
6.02
2.70
3.3
4.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
24
3.77
2.67
3.3
2.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
25
126
2.00
2.66
1.6
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
25
126
2.00
2.66
1.6
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
25
126
2.00
2.66
1.5
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
16
67
2.40
2.63
1.4
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
57
369
1.57
2.62
3.1
1.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
28
148
1.91
2.62
1.2
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
24
120
2.02
2.61
1.3
1.1
u/ml
1.7
1.3
0.21
12
46
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
24
120
2.02
2.61
1.6
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
61
403
1.54
2.57
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
24
121
2.00
2.56
1.6
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
36
208
1.75
2.55
1.7
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
20
94
2.14
2.55
1.6
1.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
7
7.16
2.55
1.2
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
15
62
2.43
2.54
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
14
56
2.52
2.53
1.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
24
122
1.98
2.51
1.6
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
130
1.94
2.46
1.3
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
53
343
1.57
2.46
1.6
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
30
166
1.83
2.46
5.1
2.8
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
21
103
2.05
2.42
1.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
18
83
2.18
2.41
1.5
1.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
27
3.35
2.39
1.2
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
89
645
1.41
2.38
1.2
1.2
iu/ml
118.4
136.6
0.20
37
249
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
14
58
2.43
2.37
1.1
1.1
u/l
83.2
71.0
—
9
41
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
14
58
2.43
2.37
1.1
1.1
u/l
24.0
18.7
—
8
39
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
58
2.43
2.37
1.3
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
58
2.43
2.37
1.3
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
14
58
2.43
2.37
3.8
3.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
55
366
1.52
2.28
3.2
2.6
g/l
0.4
0.3
0.66
33
113
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
99
2.04
2.26
1.5
1.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
9
5.57
2.21
1.0
1.2
—
—
—
0
0
(3025315) Body weight
5
9
5.57
2.21
4.0
3.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
21
107
1.98
2.21
1.2
1.1
u/ml
0.5
1.0
—
9
41
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
67
2.25
2.18
1.6
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
67
2.25
2.18
1.2
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
19
94
2.04
2.16
1.1
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
49
2.46
2.10
1.2
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
56
2.33
2.05
1.7
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
26
3.09
2.01
1.0
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
26
3.09
2.01
1.0
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
26
3.09
2.01
1.0
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
74
537
1.40
2.00
3.7
3.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
429
3835
1.17
1.99
5.2
3.9
ug/l
2.3
2.0
0.44
378
3431
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
45
2.46
1.93
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
31
188
1.66
1.92
1.2
1.2
miu/ml
101.9
215.0
—
7
77
(3017446) Testosterone [Moles/volume] in Serum or Plasma
80
595
1.37
1.89
2.5
2.2
nmol/l
14.3
14.9
0.07
65
522
(3052592) Norovirus Ag [Presence] in Stool
7
22
3.19
1.88
1.4
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
36
230
1.58
1.83
4.3
3.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
12
4.18
1.82
2.2
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
31
192
1.63
1.79
1.9
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
24
2.93
1.72
1.3
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
13
3.86
1.71
1.8
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
52
368
1.43
1.66
1.8
1.9
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
14
69
2.04
1.65
1.8
1.9
nmol/l
18.7
18.2
0.06
14
60
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1177
11431
1.20
1.64
5.6
5.0
mmol/l
6.2
6.0
4.55
1095
10307
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
21
120
1.76
1.62
1.1
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
10
43
2.34
1.60
2.2
2.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
43
2.34
1.60
1.5
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
43
2.34
1.60
1.5
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
20
3.01
1.58
1.2
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
16
85
1.89
1.55
1.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
32
208
1.55
1.55
1.4
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
33
2.43
1.54
1.1
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
20
115
1.75
1.53
2.0
1.4
%
28.0
27.9
0.00
13
73
(3011648) Oxygen content in Venous blood
17
93
1.84
1.52
1.4
1.9
%
12.2
10.7
0.84
17
93
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
27
2.60
1.51
1.1
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
131
1581
0.81
1.51
4.4
4.9
%
33.1
33.1
0.01
81
1017
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
28
178
1.58
1.49
1.8
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
37
2.44
1.48
1.0
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
37
2.44
1.48
1.0
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
37
2.44
1.48
1.0
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
37
2.44
1.48
1.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
140
1170
1.22
1.40
1.7
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
53
2.08
1.38
1.3
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
17
97
1.76
1.35
1.7
1.8
u/l
1172.8
4011.7
—
5
42
(3022493) Free Hemoglobin [Mass/volume] in Plasma
10
47
2.14
1.34
1.2
9.7
mg/l
56.8
69.4
—
5
31
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
42
2.15
1.33
1.4
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
23
144
1.61
1.32
1.2
1.1
—
19.1
—
0
7
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
44
2.05
1.27
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
27
396
0.68
1.22
1.7
1.7
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
19
116
1.65
1.21
1.4
1.3
mosm/kgh2o
273.1
275.5
0.19
14
84
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
101
1.69
1.20
1.5
1.3
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
13
71
1.84
1.19
1.5
1.9
—
12.5
—
0
5
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
25
165
1.52
1.18
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
16
95
1.69
1.14
1.1
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
58
1.90
1.12
1.3
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
25
168
1.50
1.10
5.1
4.6
umol/l
356.6
358.0
0.01
20
140
(3016018) Differential panel - Cerebral spinal fluid
17
104
1.64
1.09
1.5
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
32
228
1.41
1.06
1.5
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
71
571
1.26
1.05
1.3
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
31
220
1.42
1.05
1.3
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
82
1.71
1.05
1.4
1.1
u/ml
0.1
1.7
—
9
42
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
58
455
1.29
1.05
4.2
3.9
mmol/l
24.7
24.8
0.12
51
421
(3022621) pH of Urine by Test strip
97
809
1.21
1.04
3.5
3.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
34
2.06
1.03
1.7
1.5
—
—
—
0
0
(3010421) pH of Blood
38
281
1.36
1.03
5.4
4.3
ph
7.4
7.4
0.64
28
228
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
30
213
1.42
1.02
2.2
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
53
1.89
1.01
1.3
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
35
2.00
1.00
6.6
2.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
35
257
1.37
0.99
2.9
2.0
g/l
122.7
132.1
1.78
26
191
(3020650) Glucose [Presence] in Urine
0
29
0.00
0.97
0.0
1.8
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
16
101
1.59
0.93
3.1
2.3
u/field
3.2
2.6
—
5
38
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
17
109
1.57
0.93
1.2
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
35
464
0.75
0.93
1.7
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
55
1.82
0.92
1.2
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
29
2.07
0.89
1.3
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
71
1.70
0.89
2.2
1.9
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
13
79
1.65
0.88
1.2
1.4
promille
1.2
1.3
—
7
64
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
34
255
1.34
0.87
1.7
1.3
e6/l
1451.2
907.5
0.16
29
213
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
34
255
1.34
0.87
1.5
1.3
e6/l
18.7
39.5
0.38
28
204
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
31
1.94
0.84
1.2
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
56
453
1.25
0.83
1.9
1.7
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
8
46
1.74
0.82
1.3
1.2
—
0.1
—
0
5
(40761536) Microorganisms panel - Urine sediment
73
870
0.83
0.82
4.2
4.0
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
10
58
1.73
0.79
1.0
1.1
—
18.4
—
0
15
(3029937) Albumin [Presence] in Urine by Test strip
325
3018
1.10
0.79
5.1
4.2
estimate
0.0
0.0
0.88
83
943
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
33
1.82
0.79
1.2
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
34
261
1.31
0.77
1.9
1.8
iu/l
4.1
4.2
0.04
11
85
(3016038) Potassium [Moles/volume] in Urine
14
91
1.54
0.75
1.4
1.2
mmol/l
29.2
35.5
0.74
14
80
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
75
1.61
0.75
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
75
1.61
0.75
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
75
1.61
0.75
1.3
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
26
193
1.35
0.73
2.2
1.6
mu/l
358.7
281.6
0.59
26
177
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
25
2.00
0.72
2.6
2.2
mmol/l
1.2
1.2
—
5
25
(3029075) Extractable nuclear Ab panel - Serum
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
41
1.71
0.70
1.0
1.1
miu/ml
2616.9
1781.9
—
7
41
(40767503) Oxygen content in Capillary blood by calculation
30
230
1.31
0.69
3.7
2.4
%
15.9
16.5
0.51
21
118
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
17
118
1.45
0.69
1.2
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
21
152
1.39
0.69
1.9
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
77
1.56
0.68
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
77
1.56
0.68
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
77
1.56
0.68
1.3
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
22
161
1.37
0.68
1.5
1.3
u/l
15.4
9.3
0.63
16
130
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
59
1.53
0.68
1.3
1.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
28
1.79
0.66
1.2
2.7
—
6647.8
—
0
5
(3036071) Salmonella sp Ab [Titer] in Serum
5
28
1.79
0.66
1.2
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
29
226
1.29
0.61
1.4
1.2
iu/l
25.6
32.3
0.54
24
195
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
51
426
1.20
0.61
1.8
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
51
1.57
0.60
1.5
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
179
1641
1.10
0.59
14.6
6.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
72
1.53
0.59
1.3
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
330
3112
1.08
0.58
4.8
3.8
%
20.9
24.0
3.58
171
1501
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
13
89
1.47
0.58
1.0
1.4
—
56.7
—
0
6
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
55
1.46
0.56
1.1
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
20
261
0.76
0.54
1.4
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
61
1.48
0.53
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
39
1.54
0.53
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
39
1.54
0.53
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
39
1.54
0.53
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
39
1.54
0.53
1.2
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
39
1.54
0.53
1.3
1.5
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
11
75
1.47
0.50
1.5
1.8
—
1.7
—
0
5
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
45
1.56
0.49
1.7
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1113
10972
1.07
0.48
4.7
4.3
mmol/l
1.3
1.3
1.45
1016
9881
(3039443) Prostate specific Ag panel - Serum or Plasma
13
177
0.73
0.47
2.0
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
19
147
1.30
0.45
1.0
1.0
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
13
175
0.74
0.44
2.5
1.9
mmol/l
2.0
1.7
0.39
13
170
(3012501) Base excess in Blood by calculation
28
229
1.23
0.44
5.8
4.7
mmol/l
3.1
2.7
0.25
22
159
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
19
148
1.29
0.43
2.8
2.6
mg/l
21.6
21.7
—
5
33
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
104
1.35
0.43
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
31
1.62
0.43
1.0
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
32
1.56
0.42
4.0
3.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
32
1.56
0.42
4.0
3.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
32
1.56
0.42
1.2
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1148
11344
1.07
0.42
5.1
4.8
mmol/l
1.4
1.5
6.68
1052
10320
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
70
1.43
0.41
1.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
70
1.43
0.41
1.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
230
2172
1.07
0.41
2.9
2.7
ug/l
0.7
0.7
0.57
177
1471
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
15
0.00
0.41
0.0
2.8
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
16
0.00
0.41
0.0
2.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
20
160
1.25
0.38
1.7
1.5
%
46.9
64.7
0.83
11
103
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
37
1.35
0.37
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
37
1.35
0.37
1.2
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1182
11709
1.07
0.35
5.9
5.4
mmol/l
2.5
2.7
6.82
1084
10673
(3008898) HLA-B27 [Presence]
34
292
1.17
0.35
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
19
154
1.24
0.34
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
91
1.32
0.33
5.0
3.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
46
1.31
0.33
1.3
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
74
1.35
0.32
1.4
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
74
1.35
0.32
1.6
1.6
—
—
—
0
0
(3012565) Volume of 24 hour Urine
6
47
1.28
0.32
2.0
2.1
ml
1521.7
2049.6
—
6
39
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
15
119
1.26
0.32
1.1
1.0
—
2.2
—
0
46
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
26
304
0.85
0.30
1.8
1.5
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
7
57
1.23
0.29
6.3
6.0
—
46.8
—
0
14
(1761868) Lipid panel - Serum or Plasma
350
3616
0.96
0.29
3.8
3.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
162
0.80
0.28
1.1
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
76
1.32
0.28
2.8
1.4
g/l
0.9
1.0
—
10
76
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
63
1.27
0.27
2.0
2.5
—
—
—
0
0
(4024509)
9
119
0.75
0.27
1.8
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
65
1.23
0.27
2.6
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
75
1.20
0.25
3.0
2.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
149
1418
1.06
0.24
1.5
1.4
—
—
—
0
0
(4146454)
18
152
1.19
0.23
3.1
2.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
25
284
0.88
0.22
2.3
2.2
—
—
—
0
0
(44806071)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
10
81
1.24
0.18
1.6
1.8
—
69.1
—
0
7
(3023410) Appearance of Cerebral spinal fluid
13
109
1.19
0.18
1.9
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
60
1.17
0.17
2.0
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
61
1.15
0.17
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
14
163
0.86
0.17
1.1
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
163
0.86
0.17
1.1
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
49
526
0.93
0.17
2.0
1.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
101
1.19
0.16
1.2
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
69
1.16
0.16
3.3
2.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
151
0.86
0.15
1.1
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
14
161
0.87
0.15
1.1
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
81
1.11
0.15
1.7
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
22
198
1.11
0.14
3.6
2.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
16
141
1.14
0.14
1.9
2.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1150
11446
1.03
0.13
5.2
4.8
mmol/l
4.4
4.6
9.19
1061
10479
(3011288) Drugs identified in Urine by Screen method
12
104
1.16
0.12
1.2
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
27
290
0.93
0.10
1.3
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
14
155
0.90
0.09
1.6
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
75
0.80
0.07
1.0
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
74
1.08
0.07
10.0
12.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
76
1.05
0.07
2.3
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
324
3272
0.99
0.06
1.6
1.6
mmol/l
1.4
1.3
0.96
284
2706
(3002523) Influenza virus A Ag [Presence] in Specimen
10
111
0.90
0.06
1.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
121
0.91
0.06
1.6
2.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
109
0.92
0.04
1.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
192
1.04
0.02
2.6
3.5
%
57.5
58.1
0.07
20
192
(1002224) Polysomnography panel
40
391
1.02
0.02
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
51
518
0.98
0.01
1.8
1.7
—
—
—
0
0
(3019225) pH of Specimen
119
1197
0.99
0.00
5.0
3.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
18
182
0.99
0.00
1.6
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
123
0.98
0.00
1.0
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
19
187
1.02
0.00
2.4
3.3
e9/l
3.8
4.3
0.41
19
187
(4034850)
43
427
1.01
0.00
12.3
10.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
26
265
0.98
0.00
4.0
3.5
mg/l
49.6
27.4
1.30
19
167
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
46
455
1.01
0.00
1.8
1.6
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
4.7
—
0
5
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
13.1
—
0
5
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.2
—
7.5
—
0
5
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
54
0.93
0.00
1.2
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
49
1.02
0.00
3.0
4.2
—
—
—
0
0
(3004451) EKG impression Narrative
6
62
0.97
0.00
1.3
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
9
98
0.92
0.00
2.2
2.1
ug/l
2.3
3.0
—
9
91
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
9.1
—
0
9
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
65
0.92
0.00
1.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
6
61
0.98
0.00
1.0
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
61
0.98
0.00
1.8
1.3
nmol/l
146.2
151.1
—
6
61
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
8
0.00
0.00
0.0
1.8
—
2.0
—
0
8
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_SMALL_INTESTINE_EXALLC – Benign neoplasm: Small intestine
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).